877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

trc-canada.com, Antiparkinsonian agents

Categories

Drugs acting on the nervous system (8)
Psychoactive drugs (7)
Pharmaceuticals (5)
Phenethylamines (4)
Catecholamines (3)
Cyclic compounds (3)
AAAD inhibitors (2)
Antihypertensive agents (2)
Dopamine agonists (2)
Drugs acting on the cardiovascular system (2)
Adamantanes (1)
Alkenes (1)
Allyl compounds (1)
Alpha blockers (1)
Alpha-1 blockers (1)
Alpha-2 blockers (1)
Amines (1)
Antidepressants (1)
Antihistamines (1)
Antipsychotics (1)
Aromatic compounds (1)
Atypical antipsychotics (1)
Bases (chemistry) (1)
COMT inhibitors (1)
Chloroarenes (1)
Cycloalkanes (1)
D2 antagonists (1)
D2-receptor agonists (1)
D3 antagonists (1)
D3 receptor agonists (1)
Dopamine antagonists (1)
Dopamine reuptake inhibitors (1)
Drugs acting on the genito-urinary system (1)
Drugs for benign prostatic hyperplasia (1)
Five-membered rings (1)
H1 receptor antagonists (1)
Hormonal agents (1)
Monoamine oxidase inhibitors (1)
Monoamine releasing agents (1)
Monoamine reuptake inhibitors (1)
Mood stabilizers (1)
Nervous system drug (1)
Norepinephrine-dopamine releasing agents (1)
Piperazines (1)
Psychoanaleptics (1)
Psychopharmacology (1)
Selective estrogen receptor modulators (1)
Six-membered rings (1)
Substituted amphetamines (1)
Systemic hormonal preparations (1)
Thiazoles (1)
Urologicals (1)

Suppliers

Sigma Aldrich (5)
TCI Chemicals (4)
AK Scientific (2)
Matrix Scientific (2)
Accela (1)
Apollo Scientific (1)
Frontier Scientific (1)
Oakwood Chemical (1)
SynQuest Laboratories (1)

Aripiprazole (129722-12-9)  
Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. From April 2013 to March 2014, sales of Abilify amounted to almost $6.9 billion.. It is recommended by some doctors and used in the treatment of schizophrenia and bipolar disorder.
methyldopa (555-30-6, 41372-08-1)  
Aldomet  ·  Methyldopate  ·  alpha Methyldopa
Methyldopa, sold under the brand name Aldomet among others, is a medication used for high blood pressure. It is one of the preferred treatments for high blood pressure in pregnancy. For other types of high blood pressure including very high blood pressure resulting in symptoms other medications are typically preferred.
amantadine (768-94-5)  
Aman  ·  Symmetrel  ·  Amantadine Hydrochloride
Amantadine (trade name Symmetrel, by Endo Pharmaceuticals) is a drug that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian drug. It is the organic compound 1-adamantylamine or 1-aminoadamantane, meaning it consists of an adamantane backbone that has an amino group substituted at one of the four methyne positions.
carbidopa (28860-95-9)  
Lodosyn  ·  MK 486  ·  Methyldopahydrazine
Carbidopa (Lodosyn) is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa. This property is significant in that it allows a greater proportion of peripheral levodopa to cross the blood–brain barrier for central nervous system effect.
2-HYDROXYESTRONE (362-06-1)  
2-Hydroxyestrone (2-OHE1), also known as estra-1,3,5(10)-trien-2,3-diol-17-one, is an endogenous, naturally occurring catechol estrogen and a major metabolite of estrone and estradiol. It is formed irreversibly from estrone in the liver and to a lesser extent in other tissues via 2-hydroxylation mediated by cytochrome P450 enzymes, mainly the CYP3A and CYP1A subfamilies. 2-OHE1 is the most abundant catechol estrogen in the body.
D-Dopa (5796-17-8)  
Dopa  ·  Dihydroxyphenylalanine  ·  3,4 Dihydroxyphenylalanine
D-DOPA (D-3,4-dihydroxyphenylalanine; dextrodopa) is similar to L-DOPA (levodopa), but with opposite chirality. Levo- and dextro- rotation reference a molecule's ability to rotate planes of polarized light in either direction. Whereas L-DOPA is moderately effective in the treatment of Parkinson's disease (PD) and Dopamine-responsive dystonia (DRD) by stimulating the production of dopamine in the brain, D-DOPA is biologically inactive.
Talipexole (101626-70-4)  
Talipexole (B-HT920, Domnin) is a dopamine agonist that is marketed as a treatment for Parkinson's Disease in Japan by Boehringer Ingelheim; it was introduced in 1996. As of December 2014 it was not approved for marketing in the US nor in Europe. Talipexole is a D2 dopamine receptor agonist and interacts both pre- and post-synaptic receptors.
Related searches
trc-canada.com
Antiparkinsonian agents